Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Mohammad Ali Sheffeh, MD, from the Mayo Clinic in Rochester, Minnesota, and colleagues examined the efficacy of GLP-1 RA or SGLT-2i initiation for reducing mortality or cardiovascular events among ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

"Metformin was associated with a lowered risk of asthma attacks by approximately 30%," the researchers found. When patients ...

"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...

Real-world data on GLP-1R agonists’ safety in heart failure and CKD patients was investigated using the TriNetX Research ...

Huel, the meal replacement maker known for powdered food and “ready to drink” shakes, has posted a surge in profits as it ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...